Alnylam Pharmaceuticals, Inc.

STOREBRAND ASSET MANAGEMENT AS ALNY

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/5/2026

Shares

64,595

Value ($000)

21,373

Weight

0.1%

2020 Q1 - 2026 Q1 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/5/2026	21,373	0.1%	64,595	3/31/2026
2025 Q4	5/20/2026	29,736	0.1%	74,780	12/31/2025
2025 Q3	6/3/2026	32,840	0.1%	72,017	9/30/2025
2025 Q2	6/3/2026	14,453	0.0%	44,321	6/30/2025
2025 Q1	6/3/2026	12,164	0.0%	45,047	3/31/2025
2024 Q4	6/17/2026	10,652	0.0%	45,270	12/31/2024
2024 Q3	6/17/2026	6,376	0.0%	23,183	9/30/2024
2024 Q2	6/17/2026	2,742	0.0%	11,286	6/30/2024
2024 Q1	6/17/2026	2,766	0.0%	18,506	3/31/2024
2023 Q4	6/18/2026	6,861	0.0%	35,845	12/31/2023
2023 Q3	6/18/2026	6,004	0.0%	33,901	9/30/2023
2023 Q2	6/18/2026	7,718	0.0%	40,636	6/30/2023
2023 Q1	6/18/2026	8,336	0.0%	41,613	3/31/2023
2022 Q4	6/18/2026	10,089	0.1%	42,452	12/31/2022
2022 Q3	6/18/2026	8,246	0.0%	41,199	9/30/2022
2022 Q2	6/18/2026	6,642	0.0%	45,540	6/30/2022
2022 Q1	6/18/2026	7,488	0.0%	45,859	3/31/2022
2021 Q4	6/18/2026	8,963	0.0%	52,855	12/31/2021
2021 Q3	6/18/2026	10,065	0.0%	53,307	9/30/2021
2021 Q2	6/18/2026	9,315	0.0%	54,952	6/30/2021
2021 Q1	6/18/2026	7,759	0.0%	54,952	3/31/2021
2020 Q4	6/18/2026	6,449	0.0%	49,617	12/31/2020
2020 Q3	6/18/2026	5,457	0.0%	37,477	9/30/2020
2020 Q2	6/18/2026	5,386	0.0%	36,366	6/30/2020
2020 Q1	6/18/2026	2,986	0.0%	27,430	3/31/2020